Central modulation of cyclosporine-induced hypertension

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 388, Issue 3, 2015, Pages 351-361

  El Gowelli, Hanan M ^a   El Mas, Mahmoud M ^a  

^a Alexandria University Faculty of Pharmacy   (Egypt)

Author keywords

Arterial baroreceptors; Central nervous system; Cyclosporine; Hypertension; Sympathetic activity

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ANIMAL; CHEMICALLY INDUCED; GENETICS; HUMAN; HYPERTENSION; PATHOPHYSIOLOGY;

ANIMALS; CALCINEURIN INHIBITORS; CYCLOSPORINE; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS;

EID: 84925539807     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/s00210-014-1074-1     Document Type: Review

References (117)

1. Amundsen R, Åsberg A, Ohm IK, Christensen H (2012) Cyclosporine A- and tacrolimus-mediated inhibition of CYP3A4 and CYP3A5 in vitro. Drug Metab Dispos 40:655-661. doi: 10.1124/dmd.111.043018
2. Asai A, Qiu J, Narita Y, Chi S, Saito N, Shinoura N, Hamada H, Kuchino Y, Kirino T (1999) High level calcineurin activity predisposes neuronal cells to apoptosis. J Biol Chem 274:34450-34458
3. Bai JP, Lesko LJ, Burckart GJ (2010) Understanding the genetic basis for adverse drug effects: the calcineurin inhibitors. Pharmacotherapy 30:195-209. doi: 10.1592/phco.30.2.195
4. Basset e-EA, Berthoux P, Cécillon S, Deprle C, Thibaudin D, De Filippis JP, Alamartin E, Berthou F (2002) Hypertension after renal transplantation and polymorphism of genes involved in essential hypertension: ACE, AGT, AT1 R and ecNOS. Clin Nephrol 57:192-200
5. Bellet M, Cabrol C, Sassano P, Léger P, Corvol P, Ménard J (1985) Systemic hypertension after cardiac transplantation: effect of cyclosporine on the renin-angiotensin-aldosterone system. Am J Cardiol 56:927-931
6. Bica L, Liddell JR, Donnelly PS, Duncan C, Caragounis A, Volitakis I, Paterson BM, Cappai R, Grubman A, Camakaris J, Crouch PJ, White AR (2014) Neuroprotective copper bis(thiosemicarbazonato) complexes promote neurite elongation. PLoS One 9:e90070. doi: 10.1371/journal.pone.0090070
7. Bladen C, Vincent SR (1994) Characterization and localization of [3H] cyclosporin A binding sites in rat brain. Neuroreport 5:1386-1388
8. Borel JF, Feurer C, Gubler HU, Stähelin H (1976) Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions 6:468-475
9. Borlongan CV, Fujisaki T, Watanabe S (1998) Chronic cyclosporine-A injection in rats with damaged blood-brain barrier does not impair retention of passive avoidance. Neurosci Res 32:195-200
10. Borlongan CV, Stahl CE, Fujisaki T, Sanberg PR, Watanabe S (1999) Cyclosporine A-induced hyperactivity in rats: is it mediated by immunosuppression, neurotrophism, or both? Cell Transplant 8:153-159
11. Canzanello VJ, Textor SC, Taler SJ, Schwartz LL, Porayko MK, Wiesner RH, Krom RA (1998) Late hypertension after liver transplantation: a comparison of cyclosporine and tacrolimus (FK 506). Liver Transpl Surg 4:328-334
12. Carlos TM, Clark RS, Franicola-Higgins D, Schiding JK, Kochanek PM (1997) Expression of endothelial adhesion molecules and recruitment of neutrophils after traumatic brain injury in rats. J Leukoc Biol 61:279-285
13. Cauduro RL, Costa C, Lhulier F, Garcia RG, Cabral RD, Gonçalves LF, Manfro RC (2005) Endothelin-1 plasma levels and hypertension in cyclosporine-treated renal transplant patients. Clin Transplant 19:470-474
14. Chiu PJ, Vemulapalli S, Sabin C, Rivelli M, Bernardino V, Sybertz EJ (1992) Sympathoadrenal stimulation, not endothelin, plays a role in acute pressor response to cyclosporine in anesthetized rats. J Pharmacol Exp Ther 261:994-999
15. Dai Y, Iwanaga K, Lin YS, Hebert MF, Davis CL, Huang W, Kharasch ED, Thummel KE (2004) In vitro metabolism of cyclosporine A by human kidney CYP3A5. Biochem Pharmacol 68:1889-1902
16. Denton MD, Magee CC, Sayegh MH (1999) Immunosuppressive strategies in transplantation. Lancet 353:1083-1091
17. Despas F, Detis N, Dumonteil N, Labrunee M, Bellon B, Franchitto N, Galinier M, Senard JM, Pathak A (2009) Excessive sympathetic activation in heart failure with chronic renal failure: role of chemoreflex activation. J Hypertens 27:1849-1854. doi: 10.1097/HJH.0b013e32832e8d0f
18. Dohgu S, Nishioku T, Sumi N, Takata F, Nakagawa S, Naito M, Tsuruo T, Yamauchi A, Shuto H, Kataoka Y (2007) Adverse effect of cyclosporin A on barrier functions of cerebral microvascular endothelial cells after hypoxia-reoxygenation damage in vitro. Cell Mol Neurobiol 27:889-899
19. Dupont P, Warrens AN (2003) The evolving role of sirolimus in renal transplantation. QJM 96:401-409
20. B receptor cascade. Toxicol Appl Pharmacol 275:88-95. doi: 10.1097/FJC.0b013e318231166f
21. El-Gowilly SM (2011) Metoprolol ameliorates cyclosporine a-induced hypertension and nephrotoxicity in rats. J Cardiovasc Pharmacol 58:639-646. doi: 10.1097/FJC.0b013e318231166f
22. El-Mas MM, Abdel-Rahman AA (1995) Upregulation of imidazoline receptors in the medulla oblongata accounts for the enhanced hypotensive effect of clonidine in aortic barodenervated rats. Brain Res 691:195-204
23. El-Mas MM, Abdel-Rahman AA (1998) Estrogen enhances baroreflex control of heart rate in conscious ovariectomized rats. Can J Physiol Pharmacol 76:381-386
24. I-imidazoline but not alpha-2 adrenergic receptor-mediated reduction in vascular resistance in conscious spontaneously hypertensive rats. J Pharmacol Exp Ther 288:455-462
25. El-Mas MM, Abdel-Rahman AA (2009) Longitudinal assessment of the effects of estrogen on blood pressure and cardiovascular autonomic activity in female rats. Clin Exp Pharmacol Physiol 36:1002-1009. doi: 10.1111/j.1440-1681.2009.05192.x
26. El-Mas MM, Tao S, Carroll RG, Abdel-Rahman AA (1994) Ethanol-clonidine hemodynamic interaction in normotensive rats is modified by anesthesia. Alcohol 11:307-314
27. El-Mas MM, Afify EA, Omar AG, Sharabi FM (2002a) Cyclosporine adversely affects baroreflexes via inhibition of testosterone modulation of cardiac vagal control. J Pharmacol Exp Ther 301:346-354
28. El-Mas MM, Afify EA, Omar AG, Sharabi FM (2002b) Cyclosporine attenuates the autonomic modulation of reflex chronotropic responses in conscious rats. Can J Physiol Pharmacol 80:766-776
29. El-Mas MM, Afify EA, Omar AG, Mohy El-Din MM, Sharabi FM (2003) Testosterone depletion contributes to cyclosporine-induced chronic impairment of acetylcholine renovascular relaxations. Eur J Pharmacol 468:217-224
30. El-Mas MM, Mohy El-Din MM, El-Gowilly SM, Sharabi FM (2004a) Relative roles of endothelial relaxing factors in cyclosporine-induced impairment of cholinergic and beta-adrenergic renal vasodilations. Eur J Pharmacol 487:149-158
31. El-Mas MM, Mohy El-Din MM, El-gowilly SM, Sharabi FM (2004b) Regional and endothelial differences in the cyclosporine attenuation of adenosine receptor-mediated vasorelaxations. J Cardiovasc Pharmacol 43:562-573
32. El-Mas MM, Omar AG, Helmy MM, Mohy El-Din MM (2009) Interruption of central neuronal pathway of imidazoline I1 receptor mediates the hypertensive effect of cyclosporine in rats. Brain Res 1248:96-106. doi: 10.1016/j.brainres.2008.11.008
33. El-Mas MM, El-Gowelli HM, Abd-Elrahman KS, Saad EI, Abdel-Galil AG, Abdel-Rahman AA (2011) Pioglitazone abrogates cyclosporine-evoked hypertension via rectifying abnormalities in vascular endothelial function. Biochem Pharmacol 81:526-533. doi: 10.1016/j.bcp.2010.11.013
34. El-Mas MM, Mohy El-Din MM, Helmy MM, Omar AG (2012a) Redox imbalances incite the hypertensive, baroreflex, and autonomic effects of cyclosporine in rats. Eur J Pharmacol 694:82-88. doi: 10.1016/j.ejphar.2012.08.021
35. El-Mas MM, Omar AG, Helmy MM, Mohy El-Din MM (2012b) Crosstalk between central pathways of nitric oxide and carbon monoxide in the hypertensive action of cyclosporine. Neuropharmacology 62:1890-1896. doi: 10.1016/j.neuropharm.2011.12.017
36. 1-imidazoline sites. J Pharmacol Exp Ther 264:172-182
37. Fadel PJ, Stromstad M, Wray DW, Smith SA, Raven PB, Secher NH (2003) New insights into differential baroreflex control of heart rate in humans. Am J Physiol Heart Circ Physiol 284:H735-H743
38. Fromm MF, Schmidt BM, Pahl A, Jacobi J, Schmieder RE (2005) CYP3A5 genotype is associated with elevated blood pressure. Pharmacogenet Genomics 15:737-741
39. Gaudet E, Godwin SJ, Head GA (2000) Effects of central infusion of ANG II and losartan on the cardiac baroreflex in rabbits. Am J Physiol Heart Circ Physiol 278:H558-H566
40. Gerhardt U, Riedasch M, Hohage H (1999) Cyclosporine A modulates baroreceptor function in kidney transplant recipients. Int J Cardiol 68:203-208
41. Goto S, Matsukado Y, Mihara Y, Inoue N, Miyamoto E (1986) The distribution of calcineurin in rat brain by light and electron microscopic immunohistochemistry and enzyme-immunoassay. Brain Res 397:161-172
42. Gottschalk S, Cummins CL, Leibfritz D, Christians U, Benet LZ, Serkova NJ (2011) Age and sex differences in the effects of the immunosuppressants cyclosporine, sirolimus and everolimus on rat brain metabolism. Neurotoxicology 32:50-57. doi: 10.1016/j.neuro.2010.10.006
43. Handschumacher RE, Harding MW, Rice J, Drugge RJ, Speicher DW (1984) Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science 226:544-547
44. Hardy G, Stanke-Labesque F, Deveaux G, Devillier P, Sessa C, Bessard G (2000) Cyclosporine A and cremophor EL induce contractions of human saphenous vein: involvement of thromboxane A2 receptor-dependent pathway. J Cardiovasc Pharmacol 36:693-698
45. Hirooka Y (2008) Role of reactive oxygen species in brainstem in neural mechanisms of hypertension. Auton Neurosci 142:20-24. doi: 10.1016/j.autneu.2008.06.001
46. Hirooka Y, Kishi T, Sakai K, Takeshita A, Sunagawa K (2011) Imbalance of central nitric oxide and reactive oxygen species in the regulation of sympathetic activity and neural mechanisms of hypertension. Am J Physiol Regul Integr Comp Physiol 300:R818-R826. doi: 10.1152/ajpregu.00426.2010
47. Honzíková N, Fiser B (2009) Baroreflex sensitivity and essential hypertension in adolescents. Physiol Res 58:605-612
48. Honzikova N, Labrova R, Fiser B, Maderova E, Novakova Z, Zavodna E, Semrad B (2006) Influence of age, body mass index, and blood pressure on the carotid intima-media thickness in normotensive and hypertensive patients. Biomed Tech (Berl) 51:159-162
49. Hoorn EJ, Walsh SB, McCormick JA, Fürstenberg A, Yang CL, Roeschel T, Paliege A, Howie AJ, Conley J, Bachmann S, Unwin RJ, Ellison DH (2011) The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension. Nat Med 17:1304-1309. doi: 10.1038/nm.2497
50. Hoorn EJ, Walsh SB, McCormick JA, Zietse R, Unwin RJ, Ellison DH (2012) Pathogenesis of calcineurin inhibitor-induced hypertension. J Nephrol 25:269-275. doi: 10.5301/jn.5000174
51. Ingawale DK, Mandlik SK, Naik SR (2014) Models of hepatotoxicity and the underlying cellular, biochemical and immunological mechanism(s): a critical discussion. Environ Toxicol Pharmacol 37:118-133. doi: 10.1016/j.etap.2013.08.015
52. Issa N, Kukla A, Ibrahim HN (2013) Calcineurin inhibitor nephrotoxicity: a review and perspective of the evidence. Am J Nephrol 37:602-612. doi: 10.1159/000351648
53. Ito S, Komatsu K, Tsukamoto K, Sved AF (2001) Tonic excitatory input to the rostral ventrolateral medulla in Dahl salt-sensitive rats. Hypertension 37:687-691
54. Kasiske BL, Anjum S, Shah R, Skogen J, Kandaswamy C, Danielson B, O'Shaughnessy EA, Dahl DC, Silkensen JR, Sahadevan M, Snyder JJ (2004) Hypertension after kidney transplantation. Am J Kidney Dis 43:1071-1081
55. Klein IH, Abrahams AC, van Ede T, Oey PL, Ligtenberg G, Blankestijn PJ (2010) Differential effects of acute and sustained cyclosporine and tacrolimus on sympathetic nerve activity. J Hypertens 28:1928-1934. doi: 10.1097/HJH.0b013e32833c20eb
56. Koomans HA, Ligtenberg G (2001) Mechanisms and consequences of arterial hypertension after renal transplantation. Transplantation 72(6 Suppl):S9-S12
57. Kubista H, Boehm S (2006) Molecular mechanisms underlying the modulation of exocytotic noradrenaline release via presynaptic receptors. Pharmacol Ther 112:213-242
58. Kumada M, Terui N, Kuwaki T (1990) Arterial baroreceptor reflex: its central and peripheral neural mechanisms. Prog Neurobiol 35:331-361
59. Li YL (2013) Angiotensin II-superoxide signaling and arterial baroreceptor function in type-1 diabetes mellitus. J Diabetes Metab Suppl 12:1-6
60. Li DP, Fan ZZ, He RR (1998) Modulatory effects of endothelin on carotid baroreflex in anesthetized rats. Sheng Li Xue Bao 50:169-175
61. Li L, Hsu A, Moore PK (2009) Actions and interactions of nitric oxide, carbon monoxide and hydrogen sulphide in the cardiovascular system and in inflammation-a tale of three gases! Pharmacol Ther 123:386-400. doi: 10.1016/j.pharmthera.2009.05.005
62. Lin G, Xiang Q, Fu X, Wang S, Wang S, Chen S, Shao L, Zhao Y, Wang T (2012) Heart rate variability biofeedback decreases blood pressure in prehypertensive subjects by improving autonomic function and baroreflex. J Altern Complement Med 18:143-152. doi: 10.1089/acm.2010.0607
63. Liu J, Farmer JD Jr, Lane WS, Friedman J, Weissman I, Schreiber SL (1991) Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66:807-815
64. Liu H, Tu L, Wang Q, Sun Y, Ma Y, Cen J, Wei Q, Luo J (2013) Modulation of calcineurin activity in mouse brain by chronic oral administration of cyclosporine A. IUBMB Life 65:445-453. doi: 10.1002/iub.1139
65. Lo Russo A, Passaquin AC, Cox C, Rüegg UT (1997) Cyclosporin A potentiates receptor-activated [Ca2+]c increase. J Recept Signal Transduct Res 17:149-461
66. Louhelainen M, Merasto S, Finckenberg P, Lapatto R, Cheng ZJ, Mervaala EM (2006) Lipoic acid supplementation prevents cyclosporine-induced hypertension and nephrotoxicity in spontaneously hypertensive rats. J Hypertens 24:947-956
67. Lunde I, Bremer S, Midtvedt K, Mohebi B, Dahl M, Bergan S, Åsberg A, Christensen H (2014) The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients. Eur J Clin Pharmacol 70:685-693
68. Lyson T, McMullan DM, Ermel LD, Morgan BJ, Victor RG (1994) Mechanism of cyclosporine-induced sympathetic activation and acute hypertension in rats. Hypertension 23:667-675
69. Matsuda S, Koyasu S (2003) Regulation of MAPK signaling pathways through immunophilin-ligand complex. Curr Top Med Chem 3:1358-1367
70. Miller LW (2002) Cardiovascular toxicities of immunosuppressive agents. Am J Transplant 2:807-818
71. Moes DJ, Swen JJ, den Hartigh J, van der Straaten T, van der Heide JJ, Sanders JS, Bemelman FJ, de Fijter JW, Guchelaar HJ (2014) Effect of CYP3A4 22, CYP3A5 3, and CYP3A combined genotypes on cyclosporine, everolimus, and tacrolimus pharmacokinetics in renal transplantation. CPT Pharmacometrics Syst Pharmacol 3:e100. doi: 10.1038/psp.2013.78
72. Mohamed MK, El-Mas MM, Abdel-Rahman AA (1999) Estrogen enhancement of baroreflex sensitivity is centrally mediated. Am J Physiol 276(Regulatory Integrative Comp. Physiol. 45):R1030-R1037
73. Moreira TS, Takakura AC, Menani JV, Sato MA, Colombari E (2004) Central blockade of nitric oxide synthesis reduces moxonidine-induced hypotension. Br J Pharmacol 142:765-771
74. Morgan BJ, Lyson T, Scherrer U, Victor RG (1991) Cyclosporine causes sympathetically mediated elevations in arterial pressure in rats. Hypertension 18:458-466
75. Moss NG, Powell SL, Falk RJ (1985) Intravenous cyclosporine activates afferent and efferent renal nerves and causes sodium retention in innervated kidneys in rats. Proc Natl Acad Sci U S A 82:8222-8226
76. Nash EF, Stephenson A, Helm EJ, Durie PR, Tullis E, Singer LG, Chaparro C (2011) Impact of lung transplantation on serum lipids in adults with cystic fibrosis. J Heart Lung Transplant 30:188-193. doi: 10.1016/j.healun.2010.08.024
77. Nasser SA, El-Mas MM (2014) Endothelin ETA receptor antagonism in cardiovascular disease. Eur J Pharmacol 737:210-213. doi: 10.1016/j.ejphar.2014.05.046
78. Nasser SA, Elmallah AI, Sabra R, Khedr MM, El-Din MM, El-Mas MM (2014) Blockade of endothelin ET(A), but not thromboxane, receptors offsets the cyclosporine-evoked hypertension and interrelated baroreflex and vascular dysfunctions. Eur J Pharmacol 727:52-59. doi: 10.1016/j.ejphar.2014.01.034
79. Navegantes LC, Mendes GE, Lira EC, Kettelhut Ido C, Baptista MA, Burdmann EA (2006) Effect of cyclosporine a on glucose interstitial concentration in renal cortex and medulla from rats. Am J Nephrol 26:163-169
80. Nishiyama A, Kobori H, Fukui T, Zhang GX, Yao L, Rahman M, Hitomi H, Kiyomoto H, Shokoji T, Kimura S, Kohno M, Abe Y (2003) Role of angiotensin II and reactive oxygen species in cyclosporine A-dependent hypertension. Hypertension 42:754-760
81. Niu T, Chen X, Xu X (2002) Angiotensin converting enzyme gene insertion/deletion polymorphism and cardiovascular disease: therapeutic implications. Drugs 62:977-993
82. Noè A, Cappelli B, Biffi A, Chiesa R, Frugnoli I, Biral E, Finizio V, Baldoli C, Vezzulli P, Minicucci F, Fanelli G, Fiori R, Ciceri F, Roncarolo MG, Marktel S (2010) High incidence of severe cyclosporine neurotoxicity in children affected by haemoglobinopaties undergoing myeloablative haematopoietic stem cell transplantation: early diagnosis and prompt intervention ameliorates neurological outcome. Ital J Pediatr 36:14. doi: 10.1186/1824-7288-36-14
83. O'Donnell P (2013) Of mice and men: what physiological correlates of cognitive deficits in a mouse model of schizophrenia tell us about psychiatric disease. Neuron 80:265-266. doi: 10.1016/j.neuron.2013.10.012
84. Ogawa K, Hirooka Y, Shinohara K, Kishi T, Sunagawa K (2012) Inhibition of oxidative stress in rostral ventrolateral medulla improves impaired baroreflex sensitivity in stroke-prone spontaneously hypertensive rats. Int Heart J 53:193-198
85. Okonkwo DO, Melon DE, Pellicane AJ, Mutlu LK, Rubin DG, Stone JR, Helm GA (2003) Dose-response of cyclosporin A in attenuating traumatic axonal injury in rat. Neuroreport 14:463-466
86. Ouisuwan S, Buranakarl C (2005) Effects of cyclosporin A on blood pressure, baroreceptor reflex and renal function in dogs. Vet Res Commun 29:201-213
87. Pacheco-López G, Doenlen R, Krügel U, Arnold M, Wirth T, Riether C, Engler A, Niemi MB, Christians U, Engler H, Schedlowski M (2013) Neurobehavioural activation during peripheral immunosuppression. Int J Neuropsychopharmacol 16:137-149. doi: 10.1017/S1461145711001799
88. Patsenker E, Schneider V, Ledermann M, Saegesser H, Dorn C, Hellerbrand C, Stickel F (2011) Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis. J Hepatol 55:388-398. doi: 10.1016/j.jhep.2010.10.044
89. Price CJ, Hoyda TD, Ferguson AV (2008) The area postrema: a brain monitor and integrator of systemic autonomic state. Neuroscientist 14:182-194
90. Robert N, Wong GW, Wright JM (2010) Effect of cyclosporine on blood pressure. Cochrane Database Syst Rev 1, CD007893. doi: 10.1002/14651858.CD007893
91. Roberts DJ, Goralski KB (2008) A critical overview of the influence of inflammation and infection on P-glycoprotein expression and activity in the brain. Expert Opin Drug Metab Toxicol 4:1245-1264. doi: 10.1517/17425255.4.10.1245
92. Ryuzaki M, Stahl LK, Lyson T, Victor RG, Bishop VS (1997) Sympathoexcitatory response to cyclosporin A and baroreflex resetting. Hypertension 29:576-582
93. Salgado MC, Justo SV, Joaquim LF, Fazan R Jr, Salgado HC (2006) Role of nitric oxide and prostanoids in attenuation of rapid baroreceptor resetting. Am J Physiol Heart Circ Physiol 290:H1059-H1063
94. Schwartz RB, Bravo SM, Klufas RA, Hsu L, Barnes PD, Robson CD, Antin JH (1995) Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR Am J Roentgenol 165:627-631
95. Seagard JL, Gallenberg LA, Hopp FA, Dean C (1992) Acute resetting in two functionally different types of carotid baroreceptors. Circ Res 70:559-565
96. Seibert F, Behrendt C, Schmidt S, van der Giet M, Zidek W, Westhoff TH (2011) Differential effects of cyclosporine and tacrolimus on arterial function. Transpl Int 24:708-715. doi: 10.1111/j.1432-2277.2011.01265.x
97. Sereno J, Romão AM, Parada B, Lopes P, Carvalho E, Teixeira F, Reis F (2012) Cardiorenal benefits of early versus late cyclosporine to sirolimus conversion in a rat model. J Pharmacol Pharmacother 3:143-148. doi: 10.4103/0976-500X.95513
98. Sereno J, Parada B, Rodrigues-Santos P, Lopes PC, Carvalho E, Vala H, Teixeira-Lemos E, Alves R, Figueiredo A, Mota A, Teixeira F, Reis F (2013) Serum and renal tissue markers of nephropathy in rats under immunosuppressive therapy: cyclosporine versus sirolimus. Transplant Proc 45:1149-1156. doi: 10.1016/j.transproceed.2013.02.085
99. Shaltout HA, Abdel-Rahman AA (2003) Cyclosporine induces progressive attenuation of baroreceptor heart rate response and cumulative pressor response in conscious unrestrained rats. J Pharmacol Exp Ther 305:966-973
100. Sidharthan NP, Minchin RF, Butcher NJ (2013) Cytosolic sulfotransferase 1A3 is induced by dopamine and protects neuronal cells from dopamine toxicity: role of D1 receptor-N-methyl-d-aspartate receptor coupling. J Biol Chem 288:34364-34374. doi: 10.1074/jbc.M113.493239
101. Siekierka-Harreis M, Kuhr N, Willers R, Ivens K, Grabensee B, Mondry A, Loh MC, Rump LC, Blume C (2009) Impact of genetic polymorphisms of the renin-angiotensin system and of non-genetic factors on kidney transplant function - a single-center experience. Clin Transplant 23:606-615. doi: 10.1111/j.1399-0012.2009.01033.x
102. Smit AA, Timmers HJ, Wieling W, Wagenaar M, Marres HA, Lenders JW, van Montfrans GA, Karemaker JM (2002) Long-term effects of carotid sinus denervation on arterial blood pressure in humans. Circulation 105:1329-1335
103. Stepkowski SM (2000) Molecular targets for existing and novel immunosuppressive drugs. Expert Rev Mol Med 2:1-23
104. Taler SJ, Textor SC, Canzanello VJ, Schwartz L (1999) Cyclosporin-induced hypertension: incidence, pathogenesis and management. Drug Saf 20:437-449
105. Taylor DO, Barr ML, Radovancevic B, Renlund DG, Mentzer RM Jr, Smart FW, Tolman DE, Frazier OH, Young JB, VanVeldhuisen P (1999) A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus. J Heart Lung Transplant 18:336-345
106. Timmers HJ, Wieling W, Karemaker JM, Lenders JW (2004) Cardiovascular responses to stress after carotid baroreceptor denervation in humans. Ann N Y Acad Sci 1018:515-519
107. Tkaczyszyn M, Rydlewska A, Ponikowska B, Borodulin-Nadzieja L, Banasiak W, Ponikowski P, Jankowska EA (2013) Arterial baroreflex-physiological role and assessment of functioning. Pol Merkur Lekarski 35:104-110
108. Tocci MJ, Sigal NH (1992) Recent advances in the mechanism of action of cyclosporine and FK506. Curr Opin Nephrol Hypertens 1:236-242
109. Totola LT, Alves TB, Takakura AC, Ferreira-Neto HC, Antunes VR, Menani JV, Colombari E, Moreira TS (2013) Commissural nucleus of the solitary tract regulates the antihypertensive effects elicited by moxonidine. Neuroscience 250:80-91
110. Wang Y, Golledge J (2013) Neuronal nitric oxide synthase and sympathetic nerve activity in neurovascular and metabolic systems. Curr Neurovasc Res 10:81-89
111. Wang A, Chi Z, Wang S, Wang S, Sun Q (2009) Calcineurin-mediated GABA(A) receptor dephosphorylation in rats after kainic acid-induced status epilepticus. Seizure 18:519-523. doi: 10.1016/j.seizure.2009.05.001
112. Wispelwey B, Lesse AJ, Hansen EJ, Scheld WM (1988) Haemophilus influenzae lipopolysaccharide-induced blood brain barrier permeability during experimental meningitis in the rat. J Clin Invest 82:1339-1346
113. Yanagimachi M, Naruto T, Tanoshima R, Kato H, Yokosuka T, Kajiwara R, Fujii H, Tanaka F, Goto H, Yagihashi T, Kosaki K, Yokota S (2010) Influence of CYP3A5 and ABCB1 gene polymorphisms on calcineurin inhibitor-related neurotoxicity after hematopoietic stem cell transplantation. Clin Transplant 24:855-861. doi: 10.1111/j.1399-0012.2009.01181.x
114. Ye S, Ozgur B, Campese VM (1997) Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure. Kidney Int 51:722-727
115. Ye S, Zhong H, Yanamadala V, Campese VM (2002) Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity. Am J Hypertens 15:717-724
116. Zeier M, Van Der Giet M (2011) Calcineurin inhibitor sparing regimens using m-target of rapamycin inhibitors: an opportunity to improve cardiovascular risk following kidney transplantation? Transpl Int 24:30-42. doi: 10.1111/j.1432-2277.2010.01140.x
117. Zhang W, Victor RG (2000) Calcineurin inhibitors cause renal afferent activation in rats: a novel mechanism of cyclosporine-induced hypertension. Am J Hypertens 13:999-1004